Quantum‑Si Executives Execute Routine Sell‑to‑Cover Trades Amid Steady Confidence in Protein‑Sequencing Tech
Quantum‑Si insider sell‑to‑cover transactions are routine tax‑cover moves, not a sign of a shift; investors can focus on the company’s protein‑sequencing tech and future revenue prospects.
3 minutes to read


